Diabetes Drug Empagliflozin (Jardiance- SGLT-2) Wins FDA Approval

Aug 1, 2014
2,024 views

Diabetes Drug Empagliflozin (Jardiance- SGLT-2) Wins FDA Approval. More news in next week’s issue.

GSK’s Tanzeum (GLP-1 agonist) is now available in pharmacies in the U.S.